Sun Xi Kun
- Nombre: Sun Xi Kun
- Native name: 孙锡堃
- Also Known as: 孙锡坤
- Nacionalidad: Chinese
- Género: Male
- Nacido: diciembre 12, 2004
- Edad: 21
Drama
| Nombre | Calificación |
|---|---|
Tian Xia Tong Xin
Chinese Drama, 2024, 21 eps
Gao Xiao Liang
(Papel secundario)
|
0.0
|
La Larga Estación
Chinese Drama, 2023, 12 eps
Xiao Shen Hui
(Papel secundario)
|
8.0
|
Gong Xun
Chinese Drama, 2021, 48 eps
{Li Yan Nian} Xiao An Dong
(Papel secundario)
|
7.3
|
Refinement of Faith
Chinese Drama, 2021, 45 eps
Du Chun Feng
(Papel secundario)
|
7.4
|
Faith Makes Great
Chinese Drama, 2021, 40 eps
{Bonfire in Snow Country} Tang Dou
(Papel principal)
|
7.7
|
Kua Guo Ya Lu Jiang
Chinese Drama, 2020, 40 eps
Xiao Dou Bao
(Papel secundario)
|
7.2
|
Skynet Action
Chinese Drama, 2019, 30 eps
He Xiao Shuai
(Papel secundario)
|
6.7
|
My Father My Soldier
Chinese Drama, 2018, 43 eps
Xi Gen
(Papel secundario)
|
7.0
|
Boy Hood
Chinese Drama, 2017, 39 eps
Tan Yao Yao
(Papel secundario)
|
8.0
|
Cao Cao
Chinese Drama, 2015, 41 eps
"Liu Xie" Emperor Xian of Han [Young]
(Invitado)
|
7.7
|
Gege jipo
Chinese Drama, 2014, 30 eps
Hu Hu
(Papel secundario)
|
10.0
|
Limbo Biography
Chinese Drama, 2014, 23 eps
[Little Beggar]
(Invitado)
|
6.0
|
Romance of Our Parents
Chinese Drama, 2014, 44 eps
[Secretary Yang's son]
(Invitado)
|
7.8
|
The Three Disciples of Swallow Li
Chinese Drama, 2013, 35 eps
Song Lai [Young]
(Invitado)
|
8.0
|
Protect Love Fearlessly
Chinese Drama, 2013, 36 eps
Zheng Tian Le [Young]
(Invitado)
|
10.0
|
Ying Tao 2
Chinese Drama, 2013, 38 eps
Er Mao
(Papel secundario)
|
0.0
|
Refresh 3+7
Chinese Drama, 2012, 10 eps
Tong Tong
(Papel secundario)
|
7.0
|
Legend of Jie Zhenguo
Chinese Drama, 2011, 30 eps
Feng Sheng
(Papel secundario)
|
8.0
|
Confucius
Chinese Drama, 2011, 38 eps
[King of Lu - young]
(Invitado)
|
0.0
|
Zhang Xiao Wu's Spring
Chinese Drama, 2010, 25 eps
[Child with Zhang Xiao Wu]
(Invitado)
|
7.3
|
The Myth
Chinese Drama, 2010, 50 eps
[Child slave]
(Invitado)
|
7.4
|
The Qin Empire
Chinese Drama, 2009, 51 eps
Zhao Ying Zheng [Young]
(Invitado)
|
7.8
|
Película
| Nombre | Calificación |
|---|---|
The Warriors
Chinese Movie, 2022,
Xiao Gui
(Papel secundario)
|
7.3
|
The Humbling
Chinese Movie, 2019,
(Papel secundario)
|
0.0
|
Defenders
Chinese Movie, 2017,
[Newsboy]
(Invitado)
|
0.0
|
Yin Lingzhi
Chinese Movie, 2016,
Gou Dan
(Papel secundario)
|
0.0
|
Angel Is Not Lonely
Chinese Movie, 2015,
Dou Dou
(Papel secundario)
|
0.0
|
Mortician
Chinese Movie, 2013,
Niu Xiao Bo [Young]
(Invitado)
|
7.3
|
Trending Articles
Kim Soo Hyun to make first TV appearance after a year-long hiatus
Kim Soo Hyun is set to make his first official public appearance since resuming his activities, marking his full-fledged return to the entertainment industry
Ha Young and Lee Je Hoon's new K-drama issues statement amid the actress's growing controversy
Amid the controversy over actress Ha Young's family history, the team behind the drama 'The Long Shot Trial', in which she plays the lead role, has released a statement
Cha Eun Woo in talks for a new K-drama reportedly set in 'Bon Appetit, Your Majesty' universe
Cha Eun Woo is considering an offer to star in the drama 'Seorabeol Knife' (literal title)
Lee Jong Suk's 'Iseop's Romance' announces female lead
Choi Yun Ji has been confirmed to star alongside Lee Jong Suk in 'Iseop's Romance'
'Our Sticky Love' Ha Young apologizes for lack of awareness about her family history
Actress Ha Young has acknowledged the pro-Japanese activities of her great-grandfather, Ahn Sang Ho, and personally apologized
Director Ahn Pan Seok passes away at 64
Korean media confirms director Ahn Pan Seok's passing. More details inside
'Our Sticky Love' star Ha Young's agency issues statement on family history controversy
Ha Young's agency addresses the controversy surrounding her great-grandfather Ahn Sang Ho and apologizes for its earlier statement
Kim Ji Won makes a generous donation to help children with rare diseases
Actress Kim Ji Won donated 100 million won to Seoul National University Children's Hospital to help child patients with severe, rare, and incurable diseases, as well as to improve the hospital's ward facilities
